Titan Pharma

TTNP NASDAQ
1.240
+0.040
+3.33%
Closed 16:00 07/19 EDT
Open
1.190
Prev Close
1.200
High
1.240
Low
1.160
Volume
178.01K
Avg Vol (3M)
312.13K
52 Week High
5.92
52 Week Low
1.032
% Turnover
1.32%
Market Cap
16.75M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Titan Pharma TTNP stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Titan Pharmaceuticals, Inc. (Titan) is a specialty pharmaceutical company. The Company is engaged in developing therapeutics for the treatment of medical disorders. The Company's segment is engaged in the development of pharmaceutical products. The Company's product development programs utilize its long-term drug delivery platform, ProNeura. The Company's drug candidate, Probuphine, is being developed for the long-term maintenance treatment of opioid dependence. Titan's ProNeura continuous drug delivery system consists of a small, solid rod made from a mixture of ethylene-vinyl acetate (EVA) and a drug substance. The Company focuses on developing two product development programs, the first one with a ropinirole implant for the treatment of Parkinson's disease (PD) and the second one with a Triiodothyronine (T3) implant for the treatment of hypothyroidism.
MORE >

Recently

Name
Price
%Change